(19)
(11) EP 1 534 358 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.07.2013 Bulletin 2013/28

(45) Mention of the grant of the patent:
01.05.2013 Bulletin 2013/18

(21) Application number: 03731429.1

(22) Date of filing: 29.05.2003
(51) International Patent Classification (IPC): 
A61M 1/10(2006.01)
(86) International application number:
PCT/US2003/016854
(87) International publication number:
WO 2003/106840 (24.12.2003 Gazette 2003/52)

(54)

LOW PROFILE INLET FOR AN IMPLANTABLE BLOOD PUMP

EINLASS MIT NIEDRIGEM PROFIL FÜR EINE IMPLANTIERBARE BLUTPUMPE

OUIE D'ASPIRATION AU PROFIL BAS POUR POMPE A SANG IMPLANTABLE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 13.06.2002 US 171458

(43) Date of publication of application:
01.06.2005 Bulletin 2005/22

(73) Proprietor: World Heart Corporation
Oakland, California 94621 (US)

(72) Inventors:
  • ANTAKI, James
    Pittsburgh, PA 15213 (US)
  • LUDLOW, Jed
    North Salt Lake, UT 84054 (US)
  • MILES, Scott
    Sandy, UT 84094 (US)

(74) Representative: Pawlyn, Anthony Neil 
Urquhart-Dykes & Lord LLP Tower North Central Merrion Way
Leeds LS2 8PA
Leeds LS2 8PA (GB)


(56) References cited: : 
WO-A2-99/53974
US-A- 5 322 413
US-B1- 6 302 661
 US-A- 4 403 911
US-A- 5 980 448
US-B1- 6 394 769
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).